Mar 27, 2025 / 12:00PM GMT
Operator
Good morning and welcome to PDS Biotech's fourth quarter in full year 2024 earnings conference call.
(Operator Instructions)
Tom Johnson, LifeSci Advisors, LLC.
Tom Johnson - LifeSci Advisors, LLC - Director Corporate Communications
Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results and clinical program update call. I'm joined in the calls today by the following members of the company's management team Dr. Frank Bedu Addo, Chief Executive Officer, Dr. Kirk Shepard, Chief Medical Officer, and Lars Boesgaard, Chief Financial Officer. Dr. Bedu Addo will begin with an overview of the company's recent progress in its clinical development program.
Mr. Boesgaard will review the financial results for 2024 fiscal year. And Dr. Shepard would then join the call to help address questions from covering analysts.
As a reminder, during this call, we will make forward-looking statements which are subject to various risks and uncertainties that could cause our actual results to differ materially from
Q4 2024 PDS Biotechnology Corp Earnings Call Transcript
Mar 27, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers